Loading…

Encapsulated melatonin in polycaprolactone (PCL) microparticles as a promising graft material

Electrospraying assures many advantages with taking less time and costing less relatively to the other conventional particle production methods. In this research, we investigated the encapsulation of melatonin (MEL) hormone in polycaprolactone (PCL) microparticles by using electrospraying method. Mo...

Full description

Saved in:
Bibliographic Details
Published in:Materials Science & Engineering C 2019-07, Vol.100, p.798-808
Main Authors: Gurler, Esra Bihter, Ergul, Necdet Mekki, Ozbek, Burak, Ekren, Nazmi, Oktar, Faik Nuzhet, Haskoylu, Merve Erginer, Oner, Ebru Toksoy, Eroglu, Mehmet Sayıp, Ozbeyli, Dilek, Korkut, Veysel, Temiz, Ahmet Furkan, Kocanalı, Nil, Gungordu, Rosa Juvan, Kılıckan, Duhan Berkan, Gunduz, Oguzhan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Electrospraying assures many advantages with taking less time and costing less relatively to the other conventional particle production methods. In this research, we investigated the encapsulation of melatonin (MEL) hormone in polycaprolactone (PCL) microparticles by using electrospraying method. Morphology analysis of the produced particles completed with Scanning Electron Microscopy (SEM). SEM images demonstrated that micro-particles of 3 wt% PCL solution has the most suitable particle diameter size (2.3 ± 0.64 μm) for melatonin encapsulation. According to the characterization of the particles, electrospraying parameters like optimal collecting distance, the flow rate of the solution and voltage of the system detected as 8 cm, 0.5 ml/h, and 10 kV respectively. For determining the chemical bonds of scaffold Fourier-Transform Infrared Spectroscopy (FTIR) were used and FTIR results showed that melatonin successfully loaded into PCL micro-particles. Drug release kinetics of the melatonin loaded particles indicated that melatonin released with a burst at the beginning and release behavior became sustainable over a period of 8 h with the encapsulation efficiency of about 73%. In addition, both in-vitro and in-vivo studies of the graft materials also completed. Primary human osteoblasts (HOB) cells and female Sprague Dawley rats were used in in-vitro and in-vivo studies. Test results demonstrate cell population, and bone volume of the rats grafted with composites has remarkably increased, this caused remodelling in bone structure. Overall, these findings indicate that encapsulation of melatonin in the PCL particles with electrospray method is optimum for new synthetic graft material. •Simple, economic and time-saving producing method used to obtain drug loaded microparticles which are supporting bone remodelling.•In terms of graft material, encapsulated melatonin in polycaprolactone particles very promising.
ISSN:0928-4931
1873-0191
DOI:10.1016/j.msec.2019.03.051